Close Menu

Please, Come Back!

Pharmalot's Ed Silverman wonders how pharmaceutical companies will deal with the impending "patent cliffs" they face that will leave them with no patent protection on their most popular drugs. One idea, he says, is to create an atmosphere of customer loyalty, emulating companies like Apple or Starbucks. Writing in BusinessWeek, consultants G.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.